• 1

    Ramsey SD, Newton K, Blough D, et al: Patient-level estimates of the cost of complications in diabetes in a managed-care population. .Pharmacoeconomics 16::285. ,1999. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Caballero E, Frykberg RG: Diabetic foot infections. .J Foot Ankle Surg 37::248. ,1998. .

  • 3

    Boyko WL, Doyle JJ, Ryu S, et al: Onychomycosis and its impact on secondary infection development in the diabetic population. Presented at Fourth Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 23–26, 1999; Arlington, VA..

  • 4

    Rich P: Special patient populations: onychomycosis in the diabetic patient. .J Am Acad Dermatol 35:: S10. ,1996. .

  • 5

    Cavanagh PR, Sims DSJ, Sanders LJ: Body mass is a poor predictor of peak plantar pressure in diabetic men. .Diabetes Care 14::750. ,1991. .

  • 6

    Tooke JE, Brash PD: Microvascular aspects of diabetic foot disease. .Diabet Med 13::S26. ,1996. .

  • 7

    Joseph WS: Oral treatment options for onychomycosis. .JAPMA 87::520. ,1997. .

  • 8

    Markinson BC, Monter SI, Cabrera G: Traditional approaches to treatment of onychomycosis. .JAPMA 87::551. ,1997. .

  • 9

    McInnes BD, Dockery GL: Surgical treatment of mycotic toenails. .JAPMA 87::557. ,1997. .

  • 10

    Katz HI: Possible drug interactions in oral treatment of onychomycosis. .JAPMA 87::571. ,1997. .

  • 11

    Al Fisher Associates Inc: 1997 Diabetes survey: statistical results. .JAPMA 87::575. ,1997. .

Preventing Complications in the Diabetic Patient with Toenail Onychomycosis

James J. Anarella DPM, FACFAS1, Christopher Toth DPM2, and John A. DeBello RPh, DPM
View More View Less
  • 1 Mount Sinai Hospital of Queens, Astoria, NY
  • | 2 Mount Sinai Hospital of Queens, Astoria, NY
Restricted access